{"changeSha256":"050b4ed7c290db3691b7be551a7daf362fed8558b978d77b3aff6352068890b1","changedAt":"2026-11-16","changedFields":[{"after":"PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was leuprolide.","before":"PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was leuprolide.","field":"Summary"},{"after":"2026-11-16","before":"2026-06-17","field":"Cited source date"},{"after":"2026-11-16","before":"2026-07-30","field":"Source observed date"},{"after":"ctg-observation-nct05669664-2026-06-17-1cc9e92daca2-r2","before":"ctg-observation-nct05669664-2026-06-17-1cc9e92daca2","field":"Cited source records"},{"after":"ctg-observation-nct05669664-2026-06-17-1cc9e92daca2-r2","before":"ctg-observation-nct05669664-2026-06-17-1cc9e92daca2","field":"Headline citations"},{"after":"ctg-observation-nct05669664-2026-06-17-1cc9e92daca2-r2","before":"ctg-observation-nct05669664-2026-06-17-1cc9e92daca2","field":"Summary citations"},{"after":"1. PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was leuprolide. [sources: ctg-observation-nct05669664-2026-06-17-1cc9e92daca2-r2]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct05669664-2026-06-17-1cc9e92daca2-r2]","before":"1. PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was leuprolide. [sources: ctg-observation-nct05669664-2026-06-17-1cc9e92daca2]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct05669664-2026-06-17-1cc9e92daca2]","field":"Attributable context"},{"after":"b3a5ff90419c4c0a50b967a4dcdb2433c975a8120c2f378701ac9c463645c350","before":"89e592b23c98d73045c9944adc28bbf5c628a3ebc7d2a85512423412fd1ca5c5","field":"Source snapshot commitment"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05669664-leuprolide/#version-2","version":2},"id":"story:clinicaltrials-gov-nct05669664-leuprolide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"record-updated","notice":"ClinicalTrials.gov posted a newer version of NCT05669664, with a registry update date of 2026-11-16. This version reports that observation; the earlier retained observation remains available as version 1.","peptideSlugs":["leuprolide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05669664-leuprolide/#version-1","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-observation-nct05669664-2026-06-17-1cc9e92daca2-r2","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05669664 · retained source version 2026-11-16:f51e846025c33d2a6185a83c6915ed112fda6b9b5c9880bd640e171be3a0141c","url":"https://clinicaltrials.gov/study/NCT05669664","verifiedAt":"2026-11-16"}],"subject":{"slug":"clinicaltrials-gov-nct05669664-leuprolide","type":"story"}}
